144 related articles for article (PubMed ID: 481115)
1. The inhibition of food intake in the dog by LDS, mescaline, psilocin, d-amphetamine and phenylisopropylamine derivatives.
Vaupel DB; Nozaki M; Martin WR; Bright LD; Morton EC
Life Sci; 1979 Jun; 24(26):2427-31. PubMed ID: 481115
[No Abstract] [Full Text] [Related]
2. Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat.
Tilson HA; Sparber SB
J Pharmacol Exp Ther; 1973 Feb; 184(2):376-84. PubMed ID: 4688175
[No Abstract] [Full Text] [Related]
3. An analysis of some discriminative properties of d-amphetamine.
Kuhn DM; Appel JB; Greenberg I
Psychopharmacologia; 1974; 39(1):57-66. PubMed ID: 4138622
[No Abstract] [Full Text] [Related]
4. The effect of LSD, mescaline, and D-amphetamine on the evoked "secondary discharge".
Roth WT
Psychopharmacologia; 1966; 9(3):253-8. PubMed ID: 6010545
[No Abstract] [Full Text] [Related]
5. A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats.
Cameron OG; Appel JB
Psychopharmacologia; 1973; 33(2):117-34. PubMed ID: 4272898
[No Abstract] [Full Text] [Related]
6. Psychoactive compounds and audiogenic seizure susceptibility.
Boggan WO
Life Sci; 1973 Jul; 13(2):151-9. PubMed ID: 4751412
[No Abstract] [Full Text] [Related]
7. Tolerance and cross-tolerance among psychotomimetic drugs.
Appel JB; Freedman DX
Psychopharmacologia; 1968 Sep; 13(3):267-74. PubMed ID: 5679628
[No Abstract] [Full Text] [Related]
8. Relative activity of psychotoxic drugs on the avian optic lobe.
Scholes NW; Gutnick MJ
Eur J Pharmacol; 1970; 12(3):289-96. PubMed ID: 5531373
[No Abstract] [Full Text] [Related]
9. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
Koerner J; Appel JB
Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022
[TBL] [Abstract][Full Text] [Related]
10. [Psycho-dysleptics].
Polvan O
Turk Tip Cemiy Mecm; 1966 Nov; 32(11):661-70. PubMed ID: 5979072
[No Abstract] [Full Text] [Related]
11. [Various psychodysleptic substances].
Bernik V
Rev Paul Med; 1972 Aug; 80(2):115-7. PubMed ID: 4671580
[No Abstract] [Full Text] [Related]
12. Lysergic acid diethylamide (LSD) as a discriminative cue: drugs with similar stimulus properties.
Schechter MD; Rosecrans JA
Psychopharmacologia; 1972; 26(3):313-6. PubMed ID: 5073050
[No Abstract] [Full Text] [Related]
13. Effect of Psilocybin, LSD, and mescaline on small, involuntary eye movements.
Hebbard FW; Fischer R
Psychopharmacologia; 1966; 9(2):146-56. PubMed ID: 5983913
[No Abstract] [Full Text] [Related]
14. Inhibition of isolation-induced attack behavior of mice by drugs.
Uyeno ET
J Pharm Sci; 1966 Feb; 55(2):215-6. PubMed ID: 5923276
[No Abstract] [Full Text] [Related]
15. Hallucinogens and dominance behavior of the rat.
Uyeno ET
Proc West Pharmacol Soc; 1967; 10():94. PubMed ID: 6055511
[No Abstract] [Full Text] [Related]
16. Comparison of psilocin with psilocybin, mescaline and LSD-25.
WOLBACH AB; MINER EJ; ISBELL H
Psychopharmacologia; 1962; 3():219-23. PubMed ID: 14007905
[No Abstract] [Full Text] [Related]
17. Inhibition of isolation-induced attack behavior of mice by drugs.
Uyeno ET
Proc West Pharmacol Soc; 1966; 9():62. PubMed ID: 6006186
[No Abstract] [Full Text] [Related]
18. A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism.
Stolk JM; Barchas JD; Goldstein M; Boggan W; Freedman DX
J Pharmacol Exp Ther; 1974 Apr; 189(1):42-50. PubMed ID: 4823298
[No Abstract] [Full Text] [Related]
19. The effects of psychotomimetic drugs on primary suggestibility.
Sjoberg BM; Hollister LE
Psychopharmacologia; 1965 Nov; 8(4):251-62. PubMed ID: 5885648
[No Abstract] [Full Text] [Related]
20. 2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.
Snyder SH; Faillace L; Hollister L
Science; 1967 Nov; 158(3801):669-70. PubMed ID: 4860952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
